Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease
Status:
Not yet recruiting
Trial end date:
2027-10-01
Target enrollment:
Participant gender:
Summary
The objective of the SMART trial is to compare a combination therapy using azathioprine and
subcutaneous infliximab versus ileocecal resection in patients with symptomatic small bowel
Crohn's disease.
Phase:
N/A
Details
Lead Sponsor:
Nantes University Hospital
Collaborator:
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives